| Q36149592 | A novel missense RP1 mutation in retinitis pigmentosa |
| Q90356391 | Clinical and genetic findings of a Japanese patient with RP1-related autosomal recessive retinitis pigmentosa |
| Q53155688 | Genetic characterization and disease mechanism of retinitis pigmentosa; current scenario. |
| Q36717081 | Genetic factors modifying clinical expression of autosomal dominant RP. |
| Q37678795 | Induced pluripotent stem cells for retinal degenerative diseases: a new perspective on the challenges |
| Q54449556 | Mutations in RPGR and RP2 of Chinese patients with X-linked retinitis pigmentosa. |
| Q36734545 | Perspective on genes and mutations causing retinitis pigmentosa |
| Q36585455 | Photoreceptor sensory cilia and ciliopathies: focus on CEP290, RPGR and their interacting proteins |
| Q30440790 | Prevalence of disease-causing mutations in families with autosomal dominant retinitis pigmentosa: a screen of known genes in 200 families |
| Q37952620 | RP1 and autosomal dominant rod-cone dystrophy: novel mutations, a review of published variants, and genotype-phenotype correlation |
| Q37239675 | The severity of retinal degeneration in Rp1h gene-targeted mice is dependent on genetic background |
| Q33239006 | Three novel and the common Arg677Ter RP1 protein truncating mutations causing autosomal dominant retinitis pigmentosa in a Spanish population |
| Q36661278 | Tissue inhibitors of metalloproteinases (TIMPs): their biological functions and involvement in oral disease |
| Q38074177 | Translating induced pluripotent stem cells from bench to bedside: application to retinal diseases |
| Q38801986 | Variegated yet non-random rod and cone photoreceptor disease patterns in RPGR-ORF15-associated retinal degeneration |
| Q37543267 | What drives cell morphogenesis: a look inside the vertebrate photoreceptor |